Pregled bibliografske jedinice broj: 602031
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children // Cochrane database of systematic reviews, 9 (2011), 4; 6602-1 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 602031 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Autori
Andabaka, Tea ; Nickerson, Jason ; Rojas-Reyes, Maria Ximena ; Bačić Vrca, Vesna ; Baršić, Bruno
Izvornik
Cochrane database of systematic reviews (1469-493X) 9
(2011), 4;
6602-1
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
palivizumab; monoclonal antibody; RSV; infection; children
Sažetak
Aims were to assess: the effects of prophylaxis with RSV monoclonal antibody compared with placebo, no prophylaxis or another type of prophylaxis for reducing the risk of hospitalization due to RSV infection in high- risk infants and children ; the effects of prophylaxis with RSV monoclonal antibody as assessed by the use of resources, compared with placebo, no prophylaxis or another type of prophylaxis ; the incremental costs associated with changes in resource use in patients receiving RSV monoclonal antibody prophylactically, compared with placebo, no prophylaxis or another type of prophylaxis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Klinička bolnica "Dubrava",
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
